Dorchester Wealth Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,845
| Closed | -$327K | – | 162 |
|
|
2024
Q3 | $327K | Hold |
2,845
| – | – | 0.06% | 122 |
|
|
2024
Q2 | $303K | Sell |
2,845
-100
| -3% | -$10.6K | 0.06% | 125 |
|
|
2024
Q1 | $285K | Hold |
2,945
| – | – | 0.05% | 136 |
|
|
2023
Q4 | $297K | Hold |
2,945
| – | – | 0.06% | 129 |
|
|
2023
Q3 | $300K | Hold |
2,945
| – | – | 0.06% | 124 |
|
|
2023
Q2 | $297K | Hold |
2,945
| – | – | 0.06% | 118 |
|
|
2023
Q1 | $271K | Hold |
2,945
| – | – | 0.06% | 129 |
|
|
2022
Q4 | $267K | Hold |
2,945
| – | – | 0.06% | 122 |
|
|
2022
Q3 | $224K | Hold |
2,945
| – | – | 0.05% | 137 |
|
|
2022
Q2 | $249K | Buy |
2,945
+345
| +13% | +$29.2K | 0.05% | 135 |
|
|
2022
Q1 | $285K | Sell |
2,600
-380
| -13% | -$41.7K | 0.05% | 135 |
|
|
2021
Q4 | $261K | Hold |
2,980
| – | – | 0.05% | 130 |
|
|
2021
Q3 | $244K | Sell |
2,980
-100
| -3% | -$8.19K | 0.06% | 125 |
|
|
2021
Q2 | $281K | Hold |
3,080
| – | – | 0.06% | 133 |
|
|
2021
Q1 | $263K | Sell |
3,080
-270
| -8% | -$23.1K | 0.07% | 128 |
|
|
2020
Q4 | $316K | Hold |
3,350
| – | – | 0.08% | 114 |
|
|
2020
Q3 | $291K | Sell |
3,350
-100
| -3% | -$8.69K | 0.09% | 108 |
|
|
2020
Q2 | $301K | Hold |
3,450
| – | – | 0.1% | 107 |
|
|
2020
Q1 | $284K | Buy |
3,450
+250
| +8% | +$20.6K | 0.11% | 93 |
|
|
2019
Q4 | $303K | Buy |
3,200
+85
| +3% | +$8.05K | 0.08% | 102 |
|
|
2019
Q3 | $271K | Hold |
3,115
| – | – | 0.08% | 104 |
|
|
2019
Q2 | $284K | Buy |
3,115
+526
| +20% | +$48K | 0.08% | 106 |
|
|
2019
Q1 | $223K | Buy |
+2,589
| New | +$223K | 0.07% | 114 |
|